Aimcad Biotech Private Limited, a active private limited company, was established on 27 May 2013 in Santacruz, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74120MH2013PTC272456. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Ravi Kumar Pandey (Director), Ruby Pandey (Director), Shyam Kumar Keshari (Director). Past directors included Ruby Pandey, Ram Kumar Keshari, Shyam Kumar Keshari. It holds ₹7.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bldg No. 1, C-Wing, Flat No. 401 Parshuram, Housing Society, Chaki Khan, Santacruz, Maharashtra, 400055.
U74120MH2013PTC272456
272456
27 May 2013
₹2.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Aimcad Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Kumar Pandey | Director | 27 May 2013 | Current |
| Ruby Pandey | Director | 25 Jan 2020 | Current |
| Shyam Kumar Keshari | Director | 19 Dec 2019 | Current |
| Priyanka Keshari | Director | 19 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Dec 2019 | Past |
| Pramod Abcsdd | Director | 22 Oct 2013 | Past |
| Pramod Abcsdd | Director | 08 Jan 2014 | Past |
| Pramod Abcsdd | Director | 02 Oct 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aimcad Biotech Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.9% increase. The company also saw a substantial improvement in profitability, with a 28.21% increase in profit. The company's net worth Soared by an impressive increase of 23.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Aimcad Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2014 | Canara Bank | ₹7.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aimcad Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aimcad Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aimcad Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aimcad Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Aimcad Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Ruby Pandey was appointed as a Director was appointed as a Director on 25 Jan 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.
Progress on Shyam Kumar Keshari was appointed as a Director was appointed as a Director on 19 Dec 2019 & has been associated with this company since 5 years 11 months . was documented.
Priyanka Keshari was appointed as a Director was appointed as a Director on 19 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
Progress on A charge with Canara Bank of Rs. 7.00 M registered on 29 Jan 2014 with Charge ID 10495689 was modified on 26 Nov 2018. was documented.
The CIN of Aimcad Biotech Private Limited is U74120MH2013PTC272456.
Aimcad Biotech Private Limited is headquartered at Bldg No. 1, C-Wing, Flat No. 401 Parshuram, Housing Society, Chaki Khan, Santacruz, Maharashtra, 400055.
Aimcad Biotech Private Limited was incorporated on 27 May 2013.
The current directors of Aimcad Biotech Private Limited are
The primary industry of Aimcad Biotech Private Limited is Pharma.
Aimcad Biotech Private Limited is unlisted.
The authorized capital of Aimcad Biotech Private Limited is ₹2.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Aimcad Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX